nodes	percent_of_prediction	percent_of_DWPC	metapath
Sulfadiazine—CYP2C8—Spironolactone—dilated cardiomyopathy	0.445	1	CbGbCtD
Sulfadiazine—Drug fever—Spironolactone—dilated cardiomyopathy	0.0554	0.101	CcSEcCtD
Sulfadiazine—Diuresis—Furosemide—dilated cardiomyopathy	0.0324	0.0594	CcSEcCtD
Sulfadiazine—Anuria—Lisinopril—dilated cardiomyopathy	0.0216	0.0395	CcSEcCtD
Sulfadiazine—Eruption—Furosemide—dilated cardiomyopathy	0.0164	0.0299	CcSEcCtD
Sulfadiazine—Nephritis interstitial—Furosemide—dilated cardiomyopathy	0.0149	0.0273	CcSEcCtD
Sulfadiazine—Tubulointerstitial nephritis—Furosemide—dilated cardiomyopathy	0.0131	0.024	CcSEcCtD
Sulfadiazine—Ataxia—Spironolactone—dilated cardiomyopathy	0.0126	0.0231	CcSEcCtD
Sulfadiazine—Toxic epidermal necrolysis—Spironolactone—dilated cardiomyopathy	0.0121	0.0221	CcSEcCtD
Sulfadiazine—Stevens-Johnson syndrome—Spironolactone—dilated cardiomyopathy	0.0103	0.0188	CcSEcCtD
Sulfadiazine—Agranulocytosis—Spironolactone—dilated cardiomyopathy	0.00965	0.0177	CcSEcCtD
Sulfadiazine—Aplastic anaemia—Furosemide—dilated cardiomyopathy	0.00944	0.0173	CcSEcCtD
Sulfadiazine—Erythema multiforme—Spironolactone—dilated cardiomyopathy	0.00878	0.0161	CcSEcCtD
Sulfadiazine—Polyuria—Furosemide—dilated cardiomyopathy	0.00831	0.0152	CcSEcCtD
Sulfadiazine—Oliguria—Lisinopril—dilated cardiomyopathy	0.00819	0.015	CcSEcCtD
Sulfadiazine—Vascular purpura—Furosemide—dilated cardiomyopathy	0.00816	0.0149	CcSEcCtD
Sulfadiazine—CYP2C9—cardial valve—dilated cardiomyopathy	0.00813	0.948	CbGeAlD
Sulfadiazine—Haemolytic anaemia—Furosemide—dilated cardiomyopathy	0.00809	0.0148	CcSEcCtD
Sulfadiazine—Dermatitis exfoliative—Furosemide—dilated cardiomyopathy	0.00774	0.0142	CcSEcCtD
Sulfadiazine—Purpura—Furosemide—dilated cardiomyopathy	0.00757	0.0139	CcSEcCtD
Sulfadiazine—Anaphylactoid reaction—Furosemide—dilated cardiomyopathy	0.00754	0.0138	CcSEcCtD
Sulfadiazine—Leukopenia—Spironolactone—dilated cardiomyopathy	0.00723	0.0132	CcSEcCtD
Sulfadiazine—Anaphylactic shock—Spironolactone—dilated cardiomyopathy	0.0066	0.0121	CcSEcCtD
Sulfadiazine—Toxic epidermal necrolysis—Furosemide—dilated cardiomyopathy	0.00657	0.012	CcSEcCtD
Sulfadiazine—Thrombocytopenia—Spironolactone—dilated cardiomyopathy	0.00646	0.0118	CcSEcCtD
Sulfadiazine—Pancreatitis—Furosemide—dilated cardiomyopathy	0.00619	0.0113	CcSEcCtD
Sulfadiazine—Haemolytic anaemia—Lisinopril—dilated cardiomyopathy	0.00607	0.0111	CcSEcCtD
Sulfadiazine—Gastrointestinal disorder—Spironolactone—dilated cardiomyopathy	0.00569	0.0104	CcSEcCtD
Sulfadiazine—Anaphylactoid reaction—Lisinopril—dilated cardiomyopathy	0.00566	0.0104	CcSEcCtD
Sulfadiazine—Hypoglycaemia—Lisinopril—dilated cardiomyopathy	0.00561	0.0103	CcSEcCtD
Sulfadiazine—Stevens-Johnson syndrome—Furosemide—dilated cardiomyopathy	0.00558	0.0102	CcSEcCtD
Sulfadiazine—Agranulocytosis—Furosemide—dilated cardiomyopathy	0.00525	0.00961	CcSEcCtD
Sulfadiazine—Urticaria—Spironolactone—dilated cardiomyopathy	0.00524	0.00959	CcSEcCtD
Sulfadiazine—Body temperature increased—Spironolactone—dilated cardiomyopathy	0.00521	0.00954	CcSEcCtD
Sulfadiazine—Ataxia—Lisinopril—dilated cardiomyopathy	0.00515	0.00942	CcSEcCtD
Sulfadiazine—Toxic epidermal necrolysis—Lisinopril—dilated cardiomyopathy	0.00493	0.00902	CcSEcCtD
Sulfadiazine—Hypersensitivity—Spironolactone—dilated cardiomyopathy	0.00486	0.00889	CcSEcCtD
Sulfadiazine—Erythema multiforme—Furosemide—dilated cardiomyopathy	0.00478	0.00874	CcSEcCtD
Sulfadiazine—Tinnitus—Furosemide—dilated cardiomyopathy	0.00471	0.00862	CcSEcCtD
Sulfadiazine—Pruritus—Spironolactone—dilated cardiomyopathy	0.00467	0.00854	CcSEcCtD
Sulfadiazine—Pancreatitis—Lisinopril—dilated cardiomyopathy	0.00464	0.00849	CcSEcCtD
Sulfadiazine—Diarrhoea—Spironolactone—dilated cardiomyopathy	0.00451	0.00826	CcSEcCtD
Sulfadiazine—Depression—Lisinopril—dilated cardiomyopathy	0.00421	0.0077	CcSEcCtD
Sulfadiazine—Vomiting—Spironolactone—dilated cardiomyopathy	0.00419	0.00767	CcSEcCtD
Sulfadiazine—Stevens-Johnson syndrome—Lisinopril—dilated cardiomyopathy	0.00419	0.00766	CcSEcCtD
Sulfadiazine—Rash—Spironolactone—dilated cardiomyopathy	0.00416	0.00761	CcSEcCtD
Sulfadiazine—Dermatitis—Spironolactone—dilated cardiomyopathy	0.00415	0.0076	CcSEcCtD
Sulfadiazine—Neuropathy peripheral—Lisinopril—dilated cardiomyopathy	0.00414	0.00757	CcSEcCtD
Sulfadiazine—Headache—Spironolactone—dilated cardiomyopathy	0.00413	0.00756	CcSEcCtD
Sulfadiazine—Vertigo—Furosemide—dilated cardiomyopathy	0.00395	0.00723	CcSEcCtD
Sulfadiazine—Agranulocytosis—Lisinopril—dilated cardiomyopathy	0.00394	0.00721	CcSEcCtD
Sulfadiazine—Leukopenia—Furosemide—dilated cardiomyopathy	0.00394	0.0072	CcSEcCtD
Sulfadiazine—Nausea—Spironolactone—dilated cardiomyopathy	0.00392	0.00717	CcSEcCtD
Sulfadiazine—Hepatitis—Lisinopril—dilated cardiomyopathy	0.00379	0.00693	CcSEcCtD
Sulfadiazine—Hallucination—Lisinopril—dilated cardiomyopathy	0.00377	0.0069	CcSEcCtD
Sulfadiazine—Anaphylactic shock—Furosemide—dilated cardiomyopathy	0.00359	0.00656	CcSEcCtD
Sulfadiazine—Erythema multiforme—Lisinopril—dilated cardiomyopathy	0.00358	0.00656	CcSEcCtD
Sulfadiazine—Tinnitus—Lisinopril—dilated cardiomyopathy	0.00353	0.00646	CcSEcCtD
Sulfadiazine—Thrombocytopenia—Furosemide—dilated cardiomyopathy	0.00351	0.00643	CcSEcCtD
Sulfadiazine—Anorexia—Furosemide—dilated cardiomyopathy	0.00342	0.00626	CcSEcCtD
Sulfadiazine—Chills—Lisinopril—dilated cardiomyopathy	0.0034	0.00622	CcSEcCtD
Sulfadiazine—Decreased appetite—Furosemide—dilated cardiomyopathy	0.00312	0.00571	CcSEcCtD
Sulfadiazine—Gastrointestinal disorder—Furosemide—dilated cardiomyopathy	0.0031	0.00567	CcSEcCtD
Sulfadiazine—Vertigo—Lisinopril—dilated cardiomyopathy	0.00296	0.00542	CcSEcCtD
Sulfadiazine—Leukopenia—Lisinopril—dilated cardiomyopathy	0.00295	0.0054	CcSEcCtD
Sulfadiazine—Gastrointestinal pain—Furosemide—dilated cardiomyopathy	0.00293	0.00537	CcSEcCtD
Sulfadiazine—Urticaria—Furosemide—dilated cardiomyopathy	0.00285	0.00522	CcSEcCtD
Sulfadiazine—Abdominal pain—Furosemide—dilated cardiomyopathy	0.00284	0.00519	CcSEcCtD
Sulfadiazine—Body temperature increased—Furosemide—dilated cardiomyopathy	0.00284	0.00519	CcSEcCtD
Sulfadiazine—Arthralgia—Lisinopril—dilated cardiomyopathy	0.00281	0.00514	CcSEcCtD
Sulfadiazine—Anaphylactic shock—Lisinopril—dilated cardiomyopathy	0.00269	0.00493	CcSEcCtD
Sulfadiazine—Hypersensitivity—Furosemide—dilated cardiomyopathy	0.00264	0.00484	CcSEcCtD
Sulfadiazine—Thrombocytopenia—Lisinopril—dilated cardiomyopathy	0.00264	0.00482	CcSEcCtD
Sulfadiazine—Anorexia—Lisinopril—dilated cardiomyopathy	0.00257	0.0047	CcSEcCtD
Sulfadiazine—Pruritus—Furosemide—dilated cardiomyopathy	0.00254	0.00464	CcSEcCtD
Sulfadiazine—Diarrhoea—Furosemide—dilated cardiomyopathy	0.00246	0.00449	CcSEcCtD
Sulfadiazine—Musculoskeletal discomfort—Lisinopril—dilated cardiomyopathy	0.00245	0.00449	CcSEcCtD
Sulfadiazine—Insomnia—Lisinopril—dilated cardiomyopathy	0.00244	0.00446	CcSEcCtD
Sulfadiazine—Decreased appetite—Lisinopril—dilated cardiomyopathy	0.00234	0.00428	CcSEcCtD
Sulfadiazine—Gastrointestinal disorder—Lisinopril—dilated cardiomyopathy	0.00232	0.00425	CcSEcCtD
Sulfadiazine—Vomiting—Furosemide—dilated cardiomyopathy	0.00228	0.00417	CcSEcCtD
Sulfadiazine—Rash—Furosemide—dilated cardiomyopathy	0.00226	0.00414	CcSEcCtD
Sulfadiazine—Dermatitis—Furosemide—dilated cardiomyopathy	0.00226	0.00414	CcSEcCtD
Sulfadiazine—Headache—Furosemide—dilated cardiomyopathy	0.00225	0.00411	CcSEcCtD
Sulfadiazine—Gastrointestinal pain—Lisinopril—dilated cardiomyopathy	0.0022	0.00403	CcSEcCtD
Sulfadiazine—Urticaria—Lisinopril—dilated cardiomyopathy	0.00214	0.00391	CcSEcCtD
Sulfadiazine—Nausea—Furosemide—dilated cardiomyopathy	0.00213	0.0039	CcSEcCtD
Sulfadiazine—Abdominal pain—Lisinopril—dilated cardiomyopathy	0.00213	0.00389	CcSEcCtD
Sulfadiazine—Body temperature increased—Lisinopril—dilated cardiomyopathy	0.00213	0.00389	CcSEcCtD
Sulfadiazine—Hypersensitivity—Lisinopril—dilated cardiomyopathy	0.00198	0.00363	CcSEcCtD
Sulfadiazine—Pruritus—Lisinopril—dilated cardiomyopathy	0.0019	0.00348	CcSEcCtD
Sulfadiazine—Diarrhoea—Lisinopril—dilated cardiomyopathy	0.00184	0.00337	CcSEcCtD
Sulfadiazine—Vomiting—Lisinopril—dilated cardiomyopathy	0.00171	0.00313	CcSEcCtD
Sulfadiazine—Rash—Lisinopril—dilated cardiomyopathy	0.0017	0.00311	CcSEcCtD
Sulfadiazine—Dermatitis—Lisinopril—dilated cardiomyopathy	0.0017	0.0031	CcSEcCtD
Sulfadiazine—Headache—Lisinopril—dilated cardiomyopathy	0.00169	0.00309	CcSEcCtD
Sulfadiazine—Nausea—Lisinopril—dilated cardiomyopathy	0.0016	0.00293	CcSEcCtD
Sulfadiazine—CYP2C9—heart—dilated cardiomyopathy	0.000449	0.0524	CbGeAlD
